|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/39 | |||
| A61K 39/395 | |||
| C07K 16/28 | |||
| A61P 35/00 |
| (11) | Number of the document | 3116535 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14716752.2 |
| Date of filing the European patent application | 2014-03-12 | |
| (97) | Date of publication of the European application | 2017-01-18 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/000659 |
| Date | 2014-03-12 |
| (87) | Number | WO 2015/135558 |
| Date | 2015-09-17 |
| (72) |
FOTIN-MLECZEK, Mariola, DE
KALLEN, Karl-Josef, DE
SCHMOLLINGER, Jan C., DE
|
| (73) |
CureVac AG,
Paul-Ehrlich-Str. 15, 72076 Tübingen,
DE
|
| (54) | COMBINATION OF VACCINATION AND OX40 AGONISTS |
| COMBINATION OF VACCINATION AND OX40 AGONISTS |